Evidence map›Paper›PMID 36799223›Full record

ArticleStroke2023

A Genomic Risk Score Identifies Individuals at High Risk for Intracerebral Hemorrhage.

Evangelos Pavlos Myserlis, Marios K Georgakis, Stacie L Demel, Padmini Sekar, Jaeyoon Chung, Rainer Malik, Hyacinth I Hyacinth, Mary E Comeau, Guido J Falcone, Carl D Langefeld and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Genetics of intracerebral hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  2. Review
  3. Article
  4. Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Evangelos Pavlos Myserlis *Center for Genomic Medicine, Massachusetts General Hospital, Boston (E.P.M., M.K.G., J.R., C.D.A.).ORCID 0000-0002-7310-624X
Marios K Georgakis *Center for Genomic Medicine, Massachusetts General Hospital, Boston (E.P.M., M.K.G., J.R., C.D.A.).ORCID 0000-0003-3507-3659
Stacie L Demel *Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, OH (S.L.D., P.S., H.I.H., D.W.).ORCID 0000-0002-3000-8420
Padmini SekarDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, OH (S.L.D., P.S., H.I.H., D.W.).ORCID 0000-0002-3734-5075
Jaeyoon ChungDepartment of Medicine, Boston University School of Medicine, MA (J.C.).ORCID 0000-0002-6431-9454
Rainer MalikInstitute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University (LMU), Munich, Germany (M.K.G., R.M.).ORCID 0000-0001-9212-2520
Hyacinth I HyacinthDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, OH (S.L.D., P.S., H.I.H., D.W.).ORCID 0000-0002-1991-7463
Mary E ComeauDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC (M.E.C., C.D.L.).ORCID 0000-0001-7079-8781
Guido J FalconeDivision of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT (G.J.F.).ORCID 0000-0002-6407-0302
Carl D LangefeldDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC (M.E.C., C.D.L.).
Jonathan RosandCenter for Genomic Medicine, Massachusetts General Hospital, Boston (E.P.M., M.K.G., J.R., C.D.A.).ORCID 0000-0002-1014-9138
Daniel Woo *Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, OH (S.L.D., P.S., H.I.H., D.W.).ORCID 0000-0002-2466-7155
Christopher D Anderson *Center for Genomic Medicine, Massachusetts General Hospital, Boston (E.P.M., M.K.G., J.R., C.D.A.).ORCID 0000-0002-0053-2002
Broad Institute · USUniversity of Cincinnati Medical Center · USWake Forest University · USBoston University · USCegep de Saint Hyacinthe · CALudwig-Maximilians-Universität München · DEYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)U01NS069763 · NINDS · UNIVERSITY OF CINCINNATI · PI ANDERSON, CHRISTOPHER DAVID, DEMEL, STACIE · 2010 to 2024
$34.2M
NSTN National Clinical Coordinating CenterU01NS086872 · NINDS · UNIVERSITY OF CINCINNATI · PI Joseph Paul Broderick, Pooja Khatri · 2013 to 2026
$32.3M
Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer’s disease and its related dementiasR01AG072592 · NIA · UNIVERSITY OF CINCINNATI · PI HYACINTH, HYACINTH IDU · 2021 to 2025
$6.3M
Sickle cell disease and the functional circuit of adult-born neurons in the dentate gyrusR01HL156024 · NHLBI · UNIVERSITY OF CINCINNATI · PI HYACINTH, HYACINTH IDU · 2021 to 2025
$4.0M
Cerebrovascular Fellowship Training ProgramT32NS047996 · NINDS · UNIVERSITY OF CINCINNATI · PI Joseph Paul Broderick, Stacie Demel · 2006 to 2026
$3.7M
Sequencing Annotation and Functional Analysis in Risk of Intracerebral HemorrhageR01NS103924 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, CHRISTOPHER DAVID · 2018 to 2022
$3.4M
Mechanism of cerebral vaculopathy and stroke in sickle cell diseaseR01HL138423 · NHLBI · UNIVERSITY OF CINCINNATI · PI HYACINTH, HYACINTH IDU · 2017 to 2021
$2.5M
Intensive Blood Pressure Reduction in Deep Intracerebral HemorrhageR03NS112859 · NINDS · YALE UNIVERSITY · PI FALCONE, GUIDO JOSE, SHETH, KEVIN NAVIN · 2019 to 2020
$84k
American Heart Association-American Stroke Association 18SFRN34250007NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL138423NHLBI NIH HHS R01 HL156024NIA NIH HHS K76 AG059992NIA NIH HHS P30 AG021342NIA NIH HHS R01 AG072592NIMHD NIH HHS L60 MD013112NINDS NIH HHS R01 NS103924NINDS NIH HHS R03 NS112859NINDS NIH HHS T32 NS047996NINDS NIH HHS U01 NS069763NINDS NIH HHS U01 NS086872
6 · The paper itself

Abstract

backgroundIntracerebral hemorrhage (ICH) has an estimated heritability of 29%. We developed a genomic risk score for ICH and determined its predictive power in comparison to standard clinical risk factors.

methodsWe combined genome-wide association data from individuals of European ancestry for ICH and related traits in a meta-genomic risk score ([metaGRS]; 2.6 million variants). We tested associations with ICH and its predictive performance in addition to clinical risk factors in a held-out validation dataset (842 cases and 796 controls). We tested associations with risk of incident ICH in the population-based UK Biobank cohort (486 784 individuals, 1526 events, median follow-up 11.3 years).

resultsOne SD increment in the metaGRS was significantly associated with 31% higher odds for ICH (95% CI, 1.16-1.48) in age-, sex- and clinical risk factor-adjusted models. The metaGRS identified individuals with almost 5-fold higher odds for ICH in the top score percentile (odds ratio, 4.83 [95% CI, 1.56-21.2]). Predictive models for ICH incorporating the metaGRS in addition to clinical predictors showed superior performance compared to the clinical risk factors alone (c-index, 0.695 versus 0.686). The metaGRS showed similar associations for lobar and nonlobar ICH, independent of the known

conclusionsWe developed and validated a genomic risk score that predicts lifetime risk of ICH beyond established clinical risk factors among individuals of European ancestry. Whether implementation of the score in risk prognostication models for high-risk populations, such as patients under antithrombotic treatment, could improve clinical decision making should be explored in future studies.

Indexed as

Fibrinolytic AgentsGenome-Wide Association StudyCerebral HemorrhageGenomicsHumansRisk FactorsFibrinolytic Agentscerebral hemorrhagegeneticsgenomicshemorrhagic strokerisk factors

Identifiers

PMID36799223
PMCPMC10050100
OpenAlexW4321164691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.